KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand

Immunogenetics

Volumn 66, Issue 11, 2014, Pages 597-611

  Nemat Gorgani, Neda ^a   Edinur, Hisham A ^b   Hollenbach, Jill A ^c   Traherne, James A ^d   Dunn, Paul P J ^e   Chambers, Geoffrey K ^f   Parham, Peter ^a   Norman, Paul J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCHOOL OF HEALTH SCIENCES   (Malaysia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e National Tissue Typing Laboratory   (New Zealand)

^f VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

HLA class I; Immune diversity; KIR; M ori; NK cells; Polynesian

Indexed keywords

HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLELE; GENETICS; HAPLOTYPE; HUMAN; NEW ZEALAND; OCEANIC ANCESTRY GROUP; POLYNESIA; POPULATION;

ALLELES; HAPLOTYPES; HLA-B ANTIGENS; HUMANS; NEW ZEALAND; OCEANIC ANCESTRY GROUP; POLYNESIA; POPULATION; RECEPTORS, KIR;

EID: 84921962492     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-014-0794-1     Document Type: Article

References (79)

1. Abi-Rached L et al (2011) The shaping of modern human immune systems by multiregional admixture with archaic humans. Science (New York, NY) 334:89–94. doi:10.1126/science.1209202
2. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B (2008) Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 118:1017–1026. doi:10.1172/jci32400
3. Anderson NH, Sadler LC, Stewart AW, Fyfe EM, McCowan LM (2012) Ethnicity, body mass index and risk of pre-eclampsia in a multiethnic New Zealand population. Aust N Z J Obstet Gynaecol 52:552–558. doi:10.1111/j.1479-828X.2012.01475.x
4. Bari R et al (2009) Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood 114:5182–5190. doi:10.1182/blood-2009-07-231977
5. Bashirova AA, Martin MP, McVicar DW, Carrington M (2006) The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7:277–300. doi:10.1146/annurev.genom.7.080505.115726
6. Bellwood P, Chambers G, Ross M, Hung H-C (2011) Are ‘cultures’ inherited? Multidisciplinary perspectives on the origins of Austronesian-speaking peoples prior to 1000 BC. In: Roberts B, Vander Linden M (eds) Investigating archaeological cultures: material culture, variability and transmission. Springer, Berlin, pp 321–354
7. Burley D, Weisler MI, Zhao JX (2012) High precision u/th dating of first Polynesian settlement. PLoS One 7:e48769. doi:10.1371/journal.pone.0048769
8. Chambers GK (2013) Genetics and the origins of the Polynesians. John Wiley & Sons, Ltd, Chichester. doi:10.1002/9780470015902.a0020808.pub2
9. Cooper MA, Colonna M, Yokoyama WM (2009) Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep 10:1103–1110. doi:10.1038/embor.2009.203
10. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M (1996) A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 156:3098–3101
11. Duggan AT et al (2014) Maternal history of Oceania from complete mtDNA genomes: contrasting ancient diversity with recent homogenization due to the Austronesian expansion. Am J Hum Genet 94:721–733. doi:10.1016/j.ajhg.2014.03.014
12. Edinur HA, Dunn PP, Hammond L, Selwyn C, Velickovic ZM, Lea RA, Chambers GK (2012) Using HLA loci to inform ancestry and health in Polynesian and Maori populations. Tissue Antigens 80:509–522. doi:10.1111/tan.12026
13. Edinur HA et al (2013) HLA and MICA polymorphism in Polynesians and New Zealand Maori: implications for ancestry and health. Hum Immunol 74:1119–1129. doi:10.1016/j.humimm.2013.06.011
14. Fernandez Vina MA et al (2012) Tracking human migrations by the analysis of the distribution of HLA alleles, lineages and haplotypes in closed and open populations. Philos Trans R Soc Lond Ser B Biol Sci 367:820–829. doi:10.1098/rstb.2011.0320
15. Frazier WR, Steiner N, Hou L, Dakshanamurthy S, Hurley CK (2013) Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand. J Immunol 190:6198–6208
16. Friedlaender JS et al (2008) The genetic structure of Pacific Islanders. PLoS Genet 4:e19. doi:10.1371/journal.pgen.0040019
17. Gendzekhadze K, Norman PJ, Abi-Rached L, Graef T, Moesta AK, Layrisse Z, Parham P (2009) Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc Natl Acad Sci U S A 106:18692–18697
18. Gomez-Lozano N, Estefania E, Williams F, Halfpenny I, Middleton D, Solis R, Vilches C (2005) The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP1, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated. Eur J Immunol 35:16–24
19. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 39:D913–D919. doi:10.1093/nar/gkq1128
20. Goodridge JP et al (2007) Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur J Immunol 37:199–211
21. Graef T et al (2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med 206:2557–2572
22. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181:1133–1144
23. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200:957–965. doi:10.1084/jem.20041214
24. Hilton HG et al (2012) Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J Immunol 189:1418–1430. doi:10.4049/jimmunol.1100431
25. Hollenbach JA, Nocedal I, Ladner MB, Single RM, Trachtenberg EA (2012) Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations. Immunogenetics 64:719–737. doi:10.1007/s00251-012-0629-x
26. Hollenbach JA et al (2013) 16(th) IHIW: population global distribution of killer immunoglobulin-like receptor (KIR) and ligands. Int J Immunogenet 40:39–45
27. Hou L, Chen M, Jiang B, Kariyawasam K, Ng J, Hurley CK (2009) In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans. Hum Immunol 70:733–737
28. Hou L, Jiang B, Chen M, Ng J, Hurley CK (2011) The characteristics of allelic polymorphism in killer-immunoglobulin-like receptor framework genes in African Americans. Immunogenetics 63:549–559. doi:10.1007/s00251-011-0536-6
29. Hurles ME, Maund E, Nicholson J, Bosch E, Renfrew C, Sykes BC, Jobling MA (2003) Native American Y chromosomes in Polynesia: the genetic impact of the Polynesian slave trade. Am J Hum Genet 72:1282–1287. doi:10.1086/374827
30. Jiang W et al (2012) Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res 22:1845–1854. doi:10.1101/gr.137976.112
31. Kayser M et al (2006) Melanesian and Asian origins of Polynesians: mtDNA and Y chromosome gradients across the Pacific. Mol Biol Evol 23:2234–2244. doi:10.1093/molbev/msl093
32. Khakoo SI, Carrington M (2006) KIR and disease: a model system or system of models? Immunol Rev 214:186–201. doi:10.1111/j.1600-065X.2006.00459.x
33. Kidd JM et al (2014) Exome capture from saliva produces high quality genomic and metagenomic data. BMC Genomics 15:262. doi:10.1186/1471-2164-15-262
34. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS (2003) KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 171:3415–3425
35. Kimura R et al (2008) Gene flow and natural selection in oceanic human populations inferred from genome-wide SNP typing. Mol Biol Evol 25:1750–1761. doi:10.1093/molbev/msn128
36. Kostyu D et al (1984) HLA in two islands of French Polynesia. Tissue Antigens 23:217–228
37. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225–274. doi:10.1146/annurev.immunol.23.021704.115526
38. Leung W et al (2004) Determinants of antileukemia effects of allogeneic NK cells. J Immunol 172:644–650
39. Liu J, Xiao Z, Ko HL, Shen M, Ren EC (2014) Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11. Proc Natl Acad Sci U S A 111:2662–2667. doi:10.1073/pnas.1322052111
40. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 31:227–258. doi:10.1146/annurev-immunol-020711-075005
41. Martin MP, Carrington M (2013) Immunogenetics of HIV disease. Immunol Rev 254:245–264. doi:10.1111/imr.12071
42. Meyer M et al (2012) A high-coverage genome sequence from an archaic Denisovan individual. Science (New York, NY) 338:222–226. doi:10.1126/science.1224344
43. Meyer D et al (2007) Single locus polymorphism of classical HLA genes. In: Hansen JA (ed) Immunobiology of the human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference, vol I. IHWG Press, Seattle, pp 653–704
44. Middleton D, Meenagh A, Gourraud PA (2007) KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 59:145–158
45. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P (2008) Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol 180:3969–3979
46. Moretta L et al (2014) Human NK Cells: from surface receptors to the therapy of leukemias and solid tumors. Front Immunol 5:87. doi:10.3389/fimmu.2014.00087
47. Narni-Mancinelli E, Ugolini S, Vivier E (2013) Tuning the threshold of natural killer cell responses. Curr Opin Immunol 25:53–58. doi:10.1016/j.coi.2012.11.005
48. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW (2001) Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52:195–205
49. Norman PJ et al (2007) Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 39:1092–1099
50. Norman PJ et al (2013) Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans. PLoS Genet 9:e1003938. doi:10.1371/journal.pgen.1003938
51. O'Connor GM et al (2014) Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity. J Immunol 192:2875–2884
52. Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201–214
53. Parham P, Moffett A (2013) Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 13:133–144
54. R Development Core Team (2008) A language and environment for statistical computing. Vienna, Austria
55. Rajagopalan S, Long EO (2012) Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc Natl Acad Sci U S A 109:20596–20601
56. Roberts RL et al (2013) Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity. Arthritis Res Ther 15:R158. doi:10.1186/ar4341
57. Robinson J, Halliwell JA, McWilliam H, Lopez R, Marsh SG (2013) IPD–the immuno polymorphism database. Nucleic Acids Res 41:D1234–D1240
58. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, Parham P (2002) Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 168:2307–2315
59. Soares P et al (2011) Ancient voyaging and Polynesian origins. Am J Hum Genet 88:239–247. doi:10.1016/j.ajhg.2011.01.009
60. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739
61. Tao SD, He YM, Ying YL, He J, Zhu FM, Lv HJ (2014) KIR3DL1 genetic diversity and phenotypic variation in the Chinese Han population. Genes Immun 15:8–15
62. Thananchai H et al (2007) Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 178:33–37
63. Thorsby E (2012) The Polynesian gene pool: an early contribution by Amerindians to Easter Island. Philos Trans R Soc Lond Ser B Biol Sci 367:812–819. doi:10.1098/rstb.2011.0319
64. Tracey MC, Carter JM (2006) Class II HLA allele polymorphism: DRB1, DQB1 and DPB1 alleles and haplotypes in the New Zealand Maori population. Tissue Antigens 68:297–302
65. Uhrberg M et al (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7:753–763
66. Underhill PA, Passarino G, Lin AA, Marzuki S, Oefner PJ, Cavalli-Sforza LL, Chambers GK (2001) Maori origins, Y-chromosome haplotypes and implications for human history in the Pacific. Hum Mutat 17:271–280. doi:10.1002/humu.23
67. Velickovic M, Velickovic Z, Dunckley H (2006) Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations. Immunogenetics 58:523–532. doi:10.1007/s00251-006-0124-3
68. Venstrom JM et al (2012) HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med 367:805–816. doi:10.1056/NEJMoa1200503
69. Vierra-Green C et al (2012) Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European–American individuals. PLoS One 7:e47491
70. Vivian JP et al (2011) Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479:401–405
71. Whyte AL, Marshall SJ, Chambers GK (2005) Human evolution in Polynesia. Hum Biol 77:157–177
72. Williams F, Maxwell LD, Halfpenny IA, Meenagh A, Sleator C, Curran MD, Middleton D (2003) Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals. Hum Immunol 64:729–732
73. Wilmshurst JM, Hunt TL, Lipo CP, Anderson AJ (2011) High-precision radiocarbon dating shows recent and rapid initial human colonization of East Polynesia. Proc Natl Acad Sci U S A 108:1815–1820. doi:10.1073/pnas.1015876108
74. Wilson MJ et al (2000) Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A 97:4778–4783. doi:10.1073/pnas.080588597
75. Winter CC, Long EO (1997) A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 158:4026–4028
76. Wollstein A et al (2010) Demographic history of Oceania inferred from genome-wide data. Curr Biol CB 20:1983–1992. doi:10.1016/j.cub.2010.10.040
77. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, Parham P (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203:633–645. doi:10.1084/jem.20051884
78. Yusa S, Catina TL, Campbell KS (2002) SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol 168:5047–5057
79. Zambello R, Teramo A, Barila G, Gattazzo C, Semenzato G (2014) Activating KIRs in chronic lymphoproliferative disorder of NK cells: protection from viruses and disease induction? Front Immunol 5:72. doi:10.3389/fimmu.2014.00072